A total of 89 Private Equity/Venture Financing deals (pending and completed) were announced in China, driven by Robotics, in the last twelve months resulting in a total deal value of over $5,353.1 million. In the LTM period, June 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $1,867.6 million, resulting in an average deal value of $233.5 million during that month. On the other hand, the month of March 2022 was the most prolific in terms of deal volume, recording a total of 11 deals, resulting in an average deal value of $52.2 million during that month.
Of the 89 deals, the deal secured between JD.com.Fang; Shanghai Weihao Chuangxin Investment Management Co., Ltd. and Horizon Robotics Inc, was the largest Private Equity/Venture Financing deal in the China, which was valued at $1,500.0 million and was completed on June 11, 2021. The second-largest deal was between GGV Capital; Goldman Sachs Asset Management LP; Harvest Capital LLC.; Pavilion Capital Pte Ltd; Redview Capital L.P.; Sinovation Ventures; Starr Capital LLC; Taihecap; U-Member Capital; Yumeng Capital and Beijing Megarobo Technology Co Ltd, while the third-largest deal was between Blue Bay capital; Boyu Capital Consultancy Co. Ltd; CICC ALPHA (Beijing) Investment Fund Management Co., Ltd; Greater Bay Area Fund; Guoqi Investment; Jiangsu Jiequan ABC State-owned Enterprise Mixed Ownership Reform Fund LP; LYFE Capital; Mirae Asset Venture Investment Co. Ltd.; Morning One Investment; Octagon Capital Group LLC; Orbimed Advisors LLC; Prosperity 7 Ventures; Sage Partners; Sanzheng Health Investment; Sequoia Capital China; SoftBank Vision Fund 2; Temasek Holdings (Private) Ltd and Keenon Robotics Co., Ltd.; Shenzhen Edge Medical Co Ltd. The GGV Capital; Goldman Sachs Asset Management LP; Harvest Capital LLC.; Pavilion Capital Pte Ltd; Redview Capital L.P.; Sinovation Ventures; Starr Capital LLC; Taihecap; U-Member Capital; Yumeng Capital-Beijing Megarobo Technology Co Ltd deal and the Blue Bay capital; Boyu Capital Consultancy Co. Ltd; CICC ALPHA (Beijing) Investment Fund Management Co., Ltd; Greater Bay Area Fund; Guoqi Investment; Jiangsu Jiequan ABC State-owned Enterprise Mixed Ownership Reform Fund LP; LYFE Capital; Mirae Asset Venture Investment Co. Ltd.; Morning One Investment; Octagon Capital Group LLC; Orbimed Advisors LLC; Prosperity 7 Ventures; Sage Partners; Sanzheng Health Investment; Sequoia Capital China; SoftBank Vision Fund 2; Temasek Holdings (Private) Ltd-Keenon Robotics Co., Ltd.; Shenzhen Edge Medical Co Ltd deal were valued at $300.0 million and $200.0 million, respectively. The fourth-largest deal was between Denso Corp; Fosun Capital Group; Gaoyuan Capital; Keboda Technology Co Ltd; Legend Capital Co Ltd; Qualcomm Ventures; Shanghai Jingkai Investment Management Partnership; Shanghai Science and Technology Venture Capital (Group) Co; Tongchuangweiye; Xiaomi Corp-Zongmu Technology (Shanghai) Co Ltd valued at $190.0 million, whereas the deal between BlueRun Ventures; Capital Today; Grand Flight Investment Management, Ltd.; JinYi Capital; SoftBank Vision Fund LP-Shanghai Gaussian Automation Technology Development Co Ltd valued at $187.7 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $2,390.0 million and accounted for nearly 44.65% of the total deals (by value) announced during the last twelve months.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward